Search research articles
Contact Us
Filters
Showing results (1-10 of 506) with videos related to
Page
of 51
Sort By:
The American Journal of Managed Care
|
February 6, 2014
An update on new and emerging therapies for relapsing-remitting multiple sclerosis
Bianca Weinstock-Guttman
Acta Neurologica Belgica
|
September 16, 2021
Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
Dejan Jakimovski, Bianca Weinstock-Guttman
CNS Drugs
|
September 21, 2004
Combination therapy for multiple sclerosis: the treatment strategy of the future?
Bianca Weinstock-Guttman, Rohit Bakshi
Nature Reviews. Neurology
|
January 6, 2018
Multiple sclerosis: Extracranial venous angioplasty is ineffective to treat MS
Robert Zivadinov, Bianca Weinstock-Guttman
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 8, 2021
Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient
Bianca Weinstock-Guttman, Dejan Jakimovski
The American Journal of Managed Care
|
February 6, 2014
Impact of diagnosis and early treatment on the course of multiple sclerosis
Katia Noyes, Bianca Weinstock-Guttman
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 29, 2013
Funding CCSVI research is/was a waste of valuable time, money and intellectual energy: no
Robert Zivadinov, Bianca Weinstock-Guttman
The Lancet. Neurology
|
July 20, 2007
New MRI criteria in the diagnosis of multiple sclerosis
Bianca Weinstock-Guttman, Robert Zivadinov
Expert Opinion on Biological Therapy
|
December 3, 2013
Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango
Sahil Gupta, Bianca Weinstock-Guttman
Nature Reviews. Neurology
|
January 11, 2012
Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS
Bianca Weinstock-Guttman, Murali Ramanathan
Page
of 51
Search research articles
Search
Showing results (1-10 of 506) with videos related to
Sort By:
Page
of 51
The American Journal of Managed Care
|
February 6, 2014
An update on new and emerging therapies for relapsing-remitting multiple sclerosis
Bianca Weinstock-Guttman
Acta Neurologica Belgica
|
September 16, 2021
Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
Dejan Jakimovski, Bianca Weinstock-Guttman
CNS Drugs
|
September 21, 2004
Combination therapy for multiple sclerosis: the treatment strategy of the future?
Bianca Weinstock-Guttman, Rohit Bakshi
Nature Reviews. Neurology
|
January 6, 2018
Multiple sclerosis: Extracranial venous angioplasty is ineffective to treat MS
Robert Zivadinov, Bianca Weinstock-Guttman
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 8, 2021
Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient
Bianca Weinstock-Guttman, Dejan Jakimovski
The American Journal of Managed Care
|
February 6, 2014
Impact of diagnosis and early treatment on the course of multiple sclerosis
Katia Noyes, Bianca Weinstock-Guttman
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 29, 2013
Funding CCSVI research is/was a waste of valuable time, money and intellectual energy: no
Robert Zivadinov, Bianca Weinstock-Guttman
The Lancet. Neurology
|
July 20, 2007
New MRI criteria in the diagnosis of multiple sclerosis
Bianca Weinstock-Guttman, Robert Zivadinov
Expert Opinion on Biological Therapy
|
December 3, 2013
Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango
Sahil Gupta, Bianca Weinstock-Guttman
Nature Reviews. Neurology
|
January 11, 2012
Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS
Bianca Weinstock-Guttman, Murali Ramanathan
Page
of 51